- This is a Live, In-Person Conference
- An email confirmation will be sent upon registering
- A week before the conference, logistical information will be sent via email
This conference is being offered free of charge.
The 5th Annual Breast Cancer Symposium, Disparities on a Cellular Level and Patient Level, is being organized in collaboration with New York Oncology Hematology (NYOH) and myMedEd, Inc. This accredited conference will offer 19.5 continuing education credits and will be held August 4-6, 2023, at the Hudson Hall in Hudson, NY.
Advances in our understanding of breast cancer's genetic and physiologic pathways have led to the development of targeted systemic therapies, improved surgical procedures and radiation techniques, and improved disease-free and overall survival benefits. This conference aims to educate the global medical oncology community in a forum that will facilitate the utilization of optimal treatment strategies and foster communication that will benefit the individual patient and the community.
Medical, surgical, and radiation oncologists, primary care physicians, gynecologists, medical professionals and health care professionals interested in breast cancer are invited to attend.
After completing this activity, participants will be able to:
- Review the recent developments in breast surgical approaches, including upfront and after neoadjuvant chemotherapy, including the decision-making approach to axillary interrogation.
- Discuss the disparities encountered and identified in the breast cancer patient.
- Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy.
- Discuss updates in breast cancer imaging for earlier detection.
- Explore the understanding of subsets of aggressive breast pathology and molecular profiling.
- Identify therapeutic advances in early and advanced hormone receptor- positive, HER2 neu overexpressing, and triple-negative breast cancer.
- Review the advances in radiation therapy and outcomes, including short- course radiation therapy and de-escalation, and who may not need radiation therapy in breast conservation.
- Describe the management of HER2-positive early breast cancer in the older patient and
- Understand the psychosocial, histologic and treatment disparities of the older breast cancer patient.
- Understanding genetic mutations and approach to treatment.
- Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy.
- Understanding the science and therapeutic options using molecular profiling for patients with breast cancer.
- Explain the mechanism of action and rationale for immunotherapy.
- Discussing the psychosocial health of the oncology health provider.
- Updates on nutritional health for patients with early and advanced breast cancer.
- Bone health and when and when not to intervene
This Activity Is Planned By myMedEd, Inc.